The DOI matches its Crossref record.
Effect of atorvastatin on LDL oxidation and antioxidants in normocholesterolemic type 2 diabetic patients
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Regarding statin use, studies have reported significant reductions in serum CoQ10 associated with statin therapy for hyperlipidaemia [77–81].”
From The Use of Medications and Dietary Supplements by Masters Athletes—A Review (2022) · cites this paper as [81]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 11
- Witztum, 1994, The oxidation hypothesis of atherosclerosis, Lancet, 344, 793, 10.1016/S0140-6736(94)92346-9 · DOI · Paper page
- Giugliano, 1996, Oxidative stress and diabetic vascular complications, Diabetes Care, 19, 257, 10.2337/diacare.19.3.257 · DOI · Paper page
- Kleinveld, 1993, Decreased in vitro oxidizability of low-density lipoprotein in hypercholesterolaemic patients treated with 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, Eur. J. Clin. Invest., 23, 289, 10.1111/j.1365-2362.1993.tb00776.x · DOI
- Human, 1997, The effect of simvastatin on the plasma antioxidant concentrations in patients with hypercholesterolemia, Clin. Chim. Acta, 263, 67, 10.1016/S0009-8981(97)06557-1 · DOI
- Oranje, 1998, Lipid peroxidation in type 2 diabetes: relationship with macrovascular disease?, Neth. J. Med., 53, 61, 10.1016/S0300-2977(98)00066-7 · DOI
- Bieri, 1979, Simultaneous determination of alfa-tocopherol and retinol in plasma or red cells by high presssure liquid chromatography, Am. J. Clin. Nutr., 32, 2143, 10.1093/ajcn/32.10.2143 · DOI · Paper page
- Edlund, 1988, Determination of coenzyme Q10, alfatocopherol and cholesterol in biological samples by coupled-column liquid chromatography with colourometric and ultraviolet detection, J. Chromatogr., 425, 87, 10.1016/0378-4347(88)80009-4 · DOI
- Velussi, 1999, Atorvastatin for the management of type 2 diabetic patients with dyslipidaemia. A mid-term (9 months) treatment experience, Diabetes, Nutr. Metab., 12, 407
- Aguilar-Salinas, 2000, Efficacy and safety of atorvastatin in hyperlipidemic, type 2 diabetic patients. A 34-week multicenter, open-label study, Atherosclerosis, 152, 489, 10.1016/S0021-9150(99)00502-X · DOI
- Chen, 1997, Short-term treatment with low-dose pravastatin attenuates oxidative susceptibility of low-density lipoprotein in hypercholesterolemic patients, Cardiovasc. Drugs Ther., 11, 787, 10.1023/A:1007722426016 · DOI
- Aviram, 1998, Atorvastatin and gemfibrozil metabolites, but not the parent drugs, are potent antioxidants against lipoprotein oxidation, Atherosclerosis, 138, 271, 10.1016/S0021-9150(98)00032-X · DOI · Paper page
Cited by
Statin Adverse Effects: A Review of the Literature and Evidence for a Mitochondrial Mechanism
Golomb, B. A., & Evans, M. A. (2008) · American Journal of Cardiovascular Drugs · doi:10.2165/0129784-200808060-00004 · Cited by 677
A systematic review and economic evaluation of statins for the prevention of coronary events
Ward, S., Lloyd Jones, M., Pandor, A., Holmes, M., Ara, R., Ryan, A., Yeo, W., & Payne, N. (2007) · Health Technology Assessment · doi:10.3310/hta11140 · Cited by 556
Banach, M., Serban, C., Ursoniu, S., Rysz, J., Muntner, P., Toth, P. P., Jones, S. R., Rizzo, M., Glasser, S. P., Watts, G. F., et al. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.07.008 · Cited by 195
The Use of Medications and Dietary Supplements by Masters Athletes—A Review
Harnett, J., Climstein, M., Walsh, J., & Gifford, J. (2022) · Current Nutrition Reports · doi:10.1007/s13668-022-00398-0 · Cited by 12
Metadata
- Authors
- Oranje, W. A., Sels, J.-P. J. E., Rondas-Colbers, G. J. W. M., Lemmens, P. J. M. R., & Wolffenbuttel, B. H. R.
- Venue
- Clinica Chimica Acta
- Publisher
- Elsevier BV
- Published
- 2001-09
- Volume
- 311
- Issue
- 2
- Pages
- 91-94
- ISSN
- 0009-8981
- Cited by
- 31
- References
- 0
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
